Search research articles
Contact Us
Filters
Showing results (291-300 of 315) with videos related to
Page
of 32
Sort By:
The Journal of Allergy and Clinical Immunology
|
June 14, 2023
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment
Eric L Simpson, Patrick M Schlievert, Takeshi Yoshida, et al.
The New England Journal of Medicine
|
October 4, 2016
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L Simpson, Thomas Bieber, Emma Guttman-Yassky, et al.
JAMA Dermatology
|
September 18, 2024
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials
Eric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
June 30, 2026
Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus
Jamie P Schlarbaum, Erin M Warshaw, Yael A Leshem, et al.
Journal of the American Academy of Dermatology
|
March 18, 2019
Navigating the landscape of core outcome set development in dermatology
Cecilia A C Prinsen, Phyllis I Spuls, Jan Kottner, et al.
The Journal of Allergy and Clinical Immunology
|
January 23, 2023
The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice
Barbara Yang, Hazel Wilkie, Mrinmoy Das, et al.
The Journal of Investigative Dermatology
|
February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
JAMA Dermatology
|
December 27, 2019
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial
Margitta Worm, Eric L Simpson, Diamant Thaçi, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
January 10, 2025
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial
Eric L Simpson, Lawrence F Eichenfield, Kim A Papp, et al.
American Journal of Clinical Dermatology
|
September 3, 2025
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
Alan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 315) with videos related to
Sort By:
Page
of 32
The Journal of Allergy and Clinical Immunology
|
June 14, 2023
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment
Eric L Simpson, Patrick M Schlievert, Takeshi Yoshida, et al.
The New England Journal of Medicine
|
October 4, 2016
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L Simpson, Thomas Bieber, Emma Guttman-Yassky, et al.
JAMA Dermatology
|
September 18, 2024
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials
Eric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
June 30, 2026
Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus
Jamie P Schlarbaum, Erin M Warshaw, Yael A Leshem, et al.
Journal of the American Academy of Dermatology
|
March 18, 2019
Navigating the landscape of core outcome set development in dermatology
Cecilia A C Prinsen, Phyllis I Spuls, Jan Kottner, et al.
The Journal of Allergy and Clinical Immunology
|
January 23, 2023
The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice
Barbara Yang, Hazel Wilkie, Mrinmoy Das, et al.
The Journal of Investigative Dermatology
|
February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
JAMA Dermatology
|
December 27, 2019
Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial
Margitta Worm, Eric L Simpson, Diamant Thaçi, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
January 10, 2025
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial
Eric L Simpson, Lawrence F Eichenfield, Kim A Papp, et al.
American Journal of Clinical Dermatology
|
September 3, 2025
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks
Alan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, et al.
Page
of 32